Relapsed Acute Lymphoblastic Leukemia (ALL) Not Yet Recruiting Phase 1 Trials for Fludarabine (DB01073)
Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL)) | Not Yet Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05705570 | A Phase I Clinical Trial Using Genetically Engineered Autologous T Cells to Express Chimeric Antigen Receptor (CAR) for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies | Treatment |